First Tracks Biotherapeutics, Inc.

US$47.90As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TRAXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$2.013B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$57
19.64%
265.86%
Hold 7|6|9|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.87
0.95
1.03
1.13
17.46%
29.01%
32.01%
38.16%
Revenue$M
126.8
128.9
131.2
137.7
11.70%
14.36%
10.73%
10.19%
Peers (US$2.013B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.180
(0.056)
(0.058)
EBIT/Intx
1.108
0.332
0.390
Own earn%
26.49
6.13
(18.42)
Sh yield%
43.24
25.08
28.08
Owners
Insiders/Inst%
0.36
27.66
Short interest%
2.99
SBC / revenue%
3.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–4
$1 testx
−0.1
Incr. ROIC%
1